AdaptHealth (AHCO) Cash from Investing Activities (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | AdaptHealth | 1.35 Bn | 1.31 Bn | 111.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.26% |
| Dec 31, 2025 | -34.21% |
| Sep 30, 2025 | -1,065.65% |
| Jun 30, 2025 | 110.05% |
| Mar 31, 2025 | -10.03% |
| Dec 31, 2024 | -60.16% |
| Sep 30, 2024 | 33.26% |
| Jun 30, 2024 | 7.53% |
| Mar 31, 2024 | 2.79% |
| Dec 31, 2023 | -17.28% |
| Sep 30, 2023 | 23.05% |
| Jun 30, 2023 | -11.87% |
| Mar 31, 2023 | 38.57% |
| Dec 31, 2022 | -52.91% |
| Sep 30, 2022 | -6.02% |
| Jun 30, 2022 | -12.28% |
| Mar 31, 2022 | 69.92% |
| Dec 31, 2021 | -42.77% |
| Sep 30, 2021 | -17.83% |
| Jun 30, 2021 | 86.96% |
| Mar 31, 2021 | -543.54% |
| Dec 31, 2020 | 63.00% |
| Sep 30, 2020 | -8,391.84% |
| Jun 30, 2020 | 94.61% |
| Mar 31, 2020 | -395.43% |
| Dec 31, 2019 | 5.14% |
| Sep 30, 2019 | -89.05% |
| Jun 30, 2019 | 52.13% |
| Mar 31, 2019 | -117.11% |
| Dec 31, 2018 | 71,274.08% |
| Sep 30, 2018 | -52.49% |
| Jun 30, 2018 | 100.18% |